These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 20596503)

  • 1. Investigation of clinical interaction between omeprazole and tacrolimus in CYP3A5 non-expressors, renal transplant recipients.
    Katsakiori PF; Papapetrou EP; Goumenos DS; Nikiforidis GC; Flordellis CS
    Ther Clin Risk Manag; 2010 Jun; 6():265-9. PubMed ID: 20596503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tacrolimus and 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors: An interaction study in CYP3A5 non-expressors, renal transplant recipients.
    Katsakiori PF; Papapetrou EP; Goumenos DS; Nikiforidis GC; Flordellis CS
    Indian J Pharmacol; 2011 Jul; 43(4):385-8. PubMed ID: 21844990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased hospital stay and allograft dysfunction in renal transplant recipients with Cyp2c19 AA variant in SNP rs4244285.
    Bosó V; Herrero MJ; Bea S; Galiana M; Marrero P; Marqués MR; Hernández J; Sánchez-Plumed J; Poveda JL; Aliño SF
    Drug Metab Dispos; 2013 Feb; 41(2):480-7. PubMed ID: 23175667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cytochrome P450 3A5 polymorphism on the pharmacokinetics of tacrolimus in renal transplant recipients.
    Htun YY; Than NN; Swe HK
    Korean J Transplant; 2020 Mar; 34(1):24-30. PubMed ID: 35770260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYP3A5*3 Genetic Polymorphism and Tacrolimus Concentration in Myanmar Renal Transplant Patients.
    Htun YY; Swe HK; Saw TM
    Transplant Proc; 2018 May; 50(4):1034-1040. PubMed ID: 29731062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYP3A5 polymorphisms and their effects on tacrolimus exposure in an ethnically diverse South African renal transplant population.
    Muller WK; Dandara C; Manning K; Mhandire D; Ensor J; Barday Z; Freercks R
    S Afr Med J; 2020 Jan; 110(2):159-166. PubMed ID: 32657689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety analysis of co-administering tacrolimus and omeprazole in renal transplant recipients - A review.
    Miedziaszczyk M; Idasiak-Piechocka I
    Biomed Pharmacother; 2023 Oct; 166():115149. PubMed ID: 37619481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyp3A4, Cyp3A5, and MDR-1 genetic influences on tacrolimus pharmacokinetics in renal transplant recipients.
    Roy JN; Barama A; Poirier C; Vinet B; Roger M
    Pharmacogenet Genomics; 2006 Sep; 16(9):659-65. PubMed ID: 16906020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of intestinal CYP2C19 genotypes on the interaction between tacrolimus and omeprazole, but not lansoprazole, in adult living-donor liver transplant patients.
    Hosohata K; Masuda S; Katsura T; Takada Y; Kaido T; Ogura Y; Oike F; Egawa H; Uemoto S; Inui K
    Drug Metab Dispos; 2009 Apr; 37(4):821-6. PubMed ID: 19139162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of CYP3A4 and CYP3A5 polymorphisms on tacrolimus pharmacokinetics in Chinese adult renal transplant recipients: a population pharmacokinetic analysis.
    Zuo XC; Ng CM; Barrett JS; Luo AJ; Zhang BK; Deng CH; Xi LY; Cheng K; Ming YZ; Yang GP; Pei Q; Zhu LJ; Yuan H; Liao HQ; Ding JJ; Wu D; Zhou YN; Jing NN; Huang ZJ
    Pharmacogenet Genomics; 2013 May; 23(5):251-61. PubMed ID: 23459029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphism of the CYP3A5 gene and its effect on tacrolimus blood level.
    Nair SS; Sarasamma S; Gracious N; George J; Anish TS; Radhakrishnan R
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():197-200. PubMed ID: 25894154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CYP3A4/5 polymorphisms affect the blood level of cyclosporine and tacrolimus in Chinese renal transplant recipients.
    Li DY; Teng RC; Zhu HJ; Fang Y
    Int J Clin Pharmacol Ther; 2013 Jun; 51(6):466-74. PubMed ID: 23557867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of
    Kim JM; Ryu JH; Lee KW; Hong SK; Yang K; Choi GS; Kim YA; Lee JY; Yi NJ; Kwon CHD; Chu CW; Suh KS; Joh JW
    J Clin Med; 2020 Sep; 9(9):. PubMed ID: 32911703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of CYP3A5 and MDR1 (ABCB1) polymorphisms on the pharmacokinetics of tacrolimus in renal transplant recipients.
    Tsuchiya N; Satoh S; Tada H; Li Z; Ohyama C; Sato K; Suzuki T; Habuchi T; Kato T
    Transplantation; 2004 Oct; 78(8):1182-7. PubMed ID: 15502717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Influence of CYP3A5, CYP3A4, ABCB1, and NR1I2 Polymorphisms on Tacrolimus Concentration in Chinese Renal Transplant Recipients.
    Liu F; Ou YM; Yu AR; Xiong L; Xin HW
    Genet Test Mol Biomarkers; 2017 Nov; 21(11):663-673. PubMed ID: 28945481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review of the effect of CYP3A5 genotype on the apparent oral clearance of tacrolimus in renal transplant recipients.
    Barry A; Levine M
    Ther Drug Monit; 2010 Dec; 32(6):708-14. PubMed ID: 20864901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors affecting the long-term response to tacrolimus in renal transplant patients: pharmacokinetic and pharmacogenetic approach.
    Katsakiori PF; Papapetrou EP; Sakellaropoulos GC; Goumenos DS; Nikiforidis GC; Flordellis CS
    Int J Med Sci; 2010 May; 7(2):94-100. PubMed ID: 20479955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-Drug Interaction between Tacrolimus and Vonoprazan in Kidney Transplant Recipients.
    Suzuki Y; Yoshihashi T; Takahashi K; Furuya K; Ohkohchi N; Oda T; Homma M
    J Clin Med; 2021 Aug; 10(17):. PubMed ID: 34501411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant patients.
    Haufroid V; Mourad M; Van Kerckhove V; Wawrzyniak J; De Meyer M; Eddour DC; Malaise J; Lison D; Squifflet JP; Wallemacq P
    Pharmacogenetics; 2004 Mar; 14(3):147-54. PubMed ID: 15167702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significant impact of gene polymorphisms on tacrolimus but not cyclosporine dosing in Asian renal transplant recipients.
    Loh PT; Lou HX; Zhao Y; Chin YM; Vathsala A
    Transplant Proc; 2008 Jun; 40(5):1690-5. PubMed ID: 18589174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.